6-甲氧基苯并二氢吡喃-3-羧酸乙酯 | 885271-71-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 中文名称: 6-甲氧基苯并二氢吡喃-3-羧酸乙酯
• 英文名称: 6-Methoxy-chroman-3-carboxylic acid ethyl ester
• 英文别名: ethyl 6-methoxy-3,4-dihydro-2H-chromene-3-carboxylate
• CAS: 885271-71-6
• 化学式: C₁₃H₁₆O₄
• 分子量: 236.268
• InChiKey: WTCDHWYGTZFIJV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2932999099

反应信息

• 作为反应物：
  描述：

  6-甲氧基苯并二氢吡喃-3-羧酸乙酯 在 lithium hydroxide 、 水 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 2.0h， 生成 6-甲氧基苯并二氢吡喃-3-羧酸
  参考文献：
  名称：

  Chroman-3-amides as potent Rho kinase inhibitors

  摘要：

  Inhibition of Rho kinase (ROCK) is an attractive strategy for the treatment of diseases such as hypertension, glaucoma, and cancer. Here we report chroman-3-amides as highly potent ROCK inhibitors with sufficient kinase selectivity, excellent cell activity, good microsomal stability, and desirable pharmacokinetic properties for study as potential therapeutic agents. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.10.080
• 作为产物：
  描述：

  在 三乙基硅烷 、 三氟乙酸 作用下， 反应 14.0h， 生成 6-甲氧基苯并二氢吡喃-3-羧酸乙酯
  参考文献：
  名称：

  Chroman-3-amides as potent Rho kinase inhibitors

  摘要：

  Inhibition of Rho kinase (ROCK) is an attractive strategy for the treatment of diseases such as hypertension, glaucoma, and cancer. Here we report chroman-3-amides as highly potent ROCK inhibitors with sufficient kinase selectivity, excellent cell activity, good microsomal stability, and desirable pharmacokinetic properties for study as potential therapeutic agents. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.10.080

文献信息

• Chroman-3-amides as potent Rho kinase inhibitors
  作者：Yen Ting Chen、Thomas D. Bannister、Amiee Weiser、Evelyn Griffin、Li Lin、Claudia Ruiz、Michael D. Cameron、Stephan Schürer、Derek Duckett、Thomas Schröter、Philip LoGrasso、Yangbo Feng

  DOI：10.1016/j.bmcl.2008.10.080

  日期：2008.12

  Inhibition of Rho kinase (ROCK) is an attractive strategy for the treatment of diseases such as hypertension, glaucoma, and cancer. Here we report chroman-3-amides as highly potent ROCK inhibitors with sufficient kinase selectivity, excellent cell activity, good microsomal stability, and desirable pharmacokinetic properties for study as potential therapeutic agents. (C) 2008 Elsevier Ltd. All rights reserved.